From: Leucopenia and treatment efficacy in advanced nasopharyngeal carcinoma
All population | Cycles <4 population | Cycles > =4 population | ||||
---|---|---|---|---|---|---|
Variable | OS | DMFS | OS | DMFS | OS | DMFS |
Leucopenia | ||||||
Mild VS Absent | ||||||
HR(95 %CI) | 0.70(0.57-0.86) | 0.79(0.63-0.98) | 0.73(0.57-0.92) | 0.87(0.66-1.14) | 0.56(0.38-0.86) | 0.56(0.37-0.86) |
p | 0.001 | 0.038 | 0.009 | 0.309 | 0.007 | 0.008 |
Severe VS Absent | ||||||
HR(95 %CI) | 0.77(0.60-0.97) | 1.01(0.78-1.31) | 0.86(0.63-1.16) | 1.10(0.79-1.54) | 0.59(0.38-0.90) | 0.73(0.46-1.14) |
P | 0.030 | 0.927 | 0.320 | 0.554 | 0.016 | 0.166 |
Mild VS Severe | ||||||
HR(95%CI) | 0.91(0.76-1.09) | 0.77(0.64-0.93) | 0.85(0.66-1.08) | 0.78(0.61-1.02) | 0.98(0.75-1.28) | 0.77(0.58-1.09) |
p | 0.314 | 0.007 | 0.191 | 0.069 | 0.887 | 0.058 |
Gender | ||||||
HR(95 %CI) | 0.62(0.51-0.75) | 0.69(0.57-0.84) | 0.63(0.50-0.79) | 0.71(0.55-0.91) | 0.61(0.45-0.84) | 0.67(0.49-0.2) |
P | <0.001 | <0.001 | <0.001 | 0.007 | 0.002 | 0.015 |
Age | ||||||
HR(95 %CI) | 1.84(1.59-2.14) | 1.09(0.93-1.27) | 1.93(1.59-2.34) | 1.14(0.94-1.39) | 1.73(1.36-2.19) | 1.01(0.77-1.30) |
P | <0.001 | 0.304 | <0.001 | 0.191 | <0.001 | 0.941 |
T-classification | ||||||
HR(95 %CI) | 1.27(1.14-1.40) | 1.09(0.99-1.22) | 1.27(1.11-1.45) | 1.11(0.96-1.27) | 1.26(1.07-1.49) | 1.08(0.91-1.27) |
P | <0.001 | 0.092 | 0.001 | 0.157 | 0.007 | 0.375 |
N-classification | ||||||
HR(95CI) | 1.56(1.43-1.70) | 1.65(1.50-1.81) | 1.70(1.51-1.90) | 1.75(1.54-1.97) | 1.39(1.21-1.60) | 1.52(1.32-1.76) |
P | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Radiotherapy | ||||||
HR(95 %CI) | 0.80(0.68-0.94) | 0.91(0.76-1.08) | 0.88(0.70-1.10) | 1.03(0.82-1.30) | 0.69(0.54-0.89) | 0.75(0.58-0.97) |
P | 0.008 | 0.273 | 0.264 | 0.764 | 0.005 | 0.030 |